As of 2025-09-18, the Intrinsic Value of Immunovant Inc (IMVT) is -12.83 USD. This IMVT valuation is based on the model Peter Lynch Fair Value. With the current market price of 15.11 USD, the upside of Immunovant Inc is -184.91%.
Based on its market price of 15.11 USD and our intrinsic valuation, Immunovant Inc (IMVT) is overvalued by 184.91%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.83 - -12.83 | -12.83 | -184.91% |
| P/E | (60.81) - (60.81) | (63.83) | -522.4% |
| DDM - Stable | (15.02) - (35.15) | (25.08) | -266.0% |
| DDM - Multi | (2.11) - (3.89) | (2.74) | -118.1% |
| Market Cap (mil) | 2,633.98 |
| Beta | 1.06 |
| Outstanding shares (mil) | 174.32 |
| Enterprise Value (mil) | 2,035.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.27% |
| Cost of Debt | 5.00% |
| WACC | 9.13% |